Ordaos

Business Services · New York, United States · 11-50 Employees

View Company Info for Free

Overview

Headquarters

228 Park 60684, New York City, New York,...

Phone Number

(201) 696-5358

Website

ordaos.bio

Revenue

$7.6 Million

Industry

Business Services Research & Development
ZI Rank: 1
Signal Type
Jan
Feb
Mar
Apr
May
Jun
ZI Rank
1
1
1
1
1
1

About Ordaos

Ordaōs specializes in the development of novel therapies through the creation of mini-proteins and single domain antibodies, aimed at enhancing drug discovery for overlooked patient populations. Utilizing a generative AI-driven Design Engine, the company efficiently designs and optimizes miniPRO proteins that are smaller, more stable, and easier to manufacture than traditional antibodies. Their innovative approach allows for rapid delivery of therapeutics, significantly reducing the time to market while ensuring high efficacy and safety. Ordaōs partners with pharmaceutical and biotech companies to maximize the success of investigational new drug applications.Explore more
Ordaos's Social MediaPopular SearchesOrdaos IncOrdaos BioSIC Code 87,873NAICS Code 54,541Show more

Ordaos Org Chart

DL
United States flag for contact location.

Chief Executive Officer

PhoneEmail
MD
United States flag for contact location.

Chief Technology Officer

PhoneEmail

PhoneEmail
Get the full picture
Sign in to uncover key details.
VB
United States flag for contact location.

Vice President, Pre-Clinical Research & Devel...

PhoneEmail

PhoneEmail
Get the full picture
Sign in to uncover key details.

Is Ordaos your ideal customer?

Let us give you the heads up on whether it's a good time to reach out

Recommended Actions

Compare Similar Companies to Ordaos

Compare insights from companies similar to Ordaos, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.

Company Name

Revenue

Number of Employees

Type

Funding

Founded In

Top Executive

Ordaos

$7.6M
11-50
Private
$5M
2019
<$5M
11-50
Private
-
2013
N/A
<$5M
11-50
Private
<$5M
2018
N/A
<$5M
1-10
Private
<$5M
2008
LD
Linda De YoungProduct Development Head
<$5M
11-50
Private
$78M
2013
HL
Henri LichensteinPresident & CEO
Illustration of an envelope

Company Profile Activity

i

Among all Business Services companies

Low Activity

High Activity

Activity Insights

Ordaos is experiencing very low activity levels compared to other companies in the Business Services sector.

What does this means?

Ordaos is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Ordaos.

Ordaos financials insights

Gather financial insights about Ordaos, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.

2022

Angel/Seed

$5M

See All Ordaos's Financials Insights

Ordaos Tech Stack

A closer look at the technologies used by Ordaos

Ordaos News & Media

Read more news

Top Business Services Companies

Frequently Asked Questions Regarding Ordaos

What is Ordaos's official website?
Ordaos's official website is ordaos.bio
What is Ordaos's Revenue?
Ordaos's revenue is $7.6 Million
What is Ordaos's SIC code?
Ordaos's SIC: 87,873
What is Ordaos's NAICS code?
Ordaos's NAICS: 54,541
How many employees does Ordaos have?
Ordaos has 11-50 employees
What industry does Ordaos belong to?
Ordaos is in the industry of: Business Services, Research & Development
What is Ordaos competition?
Ordaos top competitors include: Deep 6 Analytics, OneThree Biotech, NuMedii, LAM Therapeutics
What technology does Ordaos use?
Some of the popular technologies that Ordaos uses are: Cloudflare CDN, Google Cloud Web Serving, Google Cloud Platform, Jira
Who is the CTO of Ordaos?
Ordaos's CTO is Matthias Denecke
How do I contact Ordaos?
Ordaos contact info: Phone number: (201) 696-5358 Website: ordaos.bio
What does Ordaos do?

Ordaōs specializes in the development of novel therapies through the creation of mini-proteins and single domain antibodies, aimed at enhancing drug discovery for overlooked patient populations. Utilizing a generative AI-driven Design Engine, the company efficiently designs and optimizes miniPRO proteins that are smaller, more stable, and easier to... manufacture than traditional antibodies. Their innovative approach allows for rapid delivery of therapeutics, significantly reducing the time to market while ensuring high efficacy and safety. Ordaōs partners with pharmaceutical and biotech companies to maximize the success of investigational new drug applications.Read More

What are Ordaos social media links?
Ordaos Linkedin page
Who invested in Ordaos?
Ordaos has 5 investors including IAG Capital Partners, Banyan Pacific Capital, Citta Capital and Route 66 Ventures.
Is Ordaos a public company?
Ordaos is private company therefore does not currently have an official ticker symbol
See more information about Ordaos

Get Started with ZoomInfo

Register for free

Sign Up for Free

Get started for free! No credit card needed. Enjoy up to 25 free contacts each month at no cost.
Elevate your prospecting to the next level

Supercharge Your Prospecting

Search ZoomInfo's database of 106M+ companies and 140M+ professionals to find your next lead.
Expand your business

Grow Your Business

Reveal both personal and business contact details, including emails and phone numbers, and close your most valuable buyers.